AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced the publication of data from a multi-institutional trial of MuGard in the online edition of the journal Cancer. AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) stock opened at $020.83 in last session, and closed at $21.55, while the day range of AMAG stock is $20.69 – $21.64. The stock showed a positive weekly performance of 10.63%.
Palatin Technologies Inc (NYSEMKT:PTN) announced results for its second quarter ended December 31, 2001. Palatin Technologies, Inc. (NYSEMKT:PTN) stock opened at $1.07, in last session and closed at $1.03, by losing -3.74%. The 52 week range of PTN is $0.51 – $1.34. Company’s market capitalization is $40.37million.
Venaxis Inc. (NASDAQ:APPY)’s EPS for trailing twelve months is ($0.93) and is expected to rise to ($0.44) by the next year. Venaxis Inc (NASDAQ:APPY) finished the last session at $2.50. The EPS of the stock remained -0.93. Company’s market capitalization is $53.64million.
The $42 million market capped diagnostic substances provider Atossa Genetics Inc (NASDAQ:ATOS) seems to be headed for a long drawn out legal battle with a host of its investors, if the press notes given out by law firm Johnson & Weaver, LLP and a host of other such firms is anything to go by. Atossa Genetics Inc (NASDAQ:ATOS) stock opened the session at $2.30, and closed the session at $2.30. The 52 week range of the ATOS stock remained $1.74 – $12.40 and the day range was $2.25 – $2.35.